Form D — Kura Oncology, Inc.
0001231919-26-001602 · filed Nov 18, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $25,000,000
- Reported amount sold
- $5,000,000
- Minimum investment
- $0
- Investors
- 1
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Kura Oncology, Inc.
- CIK
- 1422143
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 4930 DIRECTORS PLACE, SUITE 500
SAN DIEGO, California 92121 - Phone
- (858) 500-8800
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Troy Wilson · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Kathleen Ford · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Jennifer Fulk · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Francis Burrows · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Mollie Leoni · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Teresa Bair · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Brian Powl · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Faheem Hasnain · DirectorSan Diego, California Find on LinkedIn ↗
-
Helen Collins · DirectorSan Diego, California Find on LinkedIn ↗
-
Thomas Malley · DirectorSan Diego, California Find on LinkedIn ↗
-
Diane Parks · DirectorSan Diego, California Find on LinkedIn ↗
-
Carol Schafer · DirectorSan Diego, California Find on LinkedIn ↗
-
Mary Szela · DirectorSan Diego, California Find on LinkedIn ↗
-
Michael Vasconcelles · DirectorSan Diego, California Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗